Latest News

Eirgen Pharma Announces HPRA Approval of New Facility in Waterford Waterford, Ireland – [March 2026]  — Eirgen Pharma is pleased to announce that its newly constructed manufacturing facility at the IDA Waterford Business Park has received full approval from the Health Products Regulatory Authority (HPRA). This certification confirms that the facility meets all Good Manufacturing Practice (GMP) requirements, authorizing the site to develop and manufacture investigational medic

In October, a dedicated team of ten team members from Eirgen—representing Business Development, Supply Chain, and NPI/R&D—arrived at CPHI Frankfurt with a clear mandate.

At Eirgen Pharma, we understand that navigating the complex web of regulations across different countries requires innovation, collaboration, and a patient-centric approach.

Eirgen Pharma is pleased to announce a significant development in our ongoing digital journey. In Q2 of the current year, we commenced development of our new Electronic Batch Record (EBR) system, internally known as Project Elevate. This initiative represents a strategic transition from traditional paper-based processes to a fully digitized system, with an anticipated launch in Q4 of 2025.